Kontafarma China Holdings Limited (HKG:1312)
0.0300
+0.0020 (7.14%)
Nov 20, 2026, 3:59 PM HKT
Kontafarma China Holdings Market Cap
Kontafarma China Holdings has a market cap or net worth of 167.66 million as of November 20, 2026. It is the 35,853rd most valuable company in the world and the 1,961st biggest in Hong Kong. Its market cap has increased by 11.11% in one year.
Market Cap
167.66M
Enterprise Value
197.88M
Revenue
845.33M
Global Rank
Country Rank
#1,961 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2012, Kontafarma China Holdings's market cap has decreased from 719.40M to 167.66M, a decrease of -76.69%. That is a compound annual growth rate of -9.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 167.66M | 3.45% |
| Dec 31, 2025 | 162.07M | 11.54% |
| Dec 31, 2024 | 145.30M | -27.78% |
| Dec 29, 2023 | 201.19M | -20.00% |
| Dec 30, 2022 | 251.49M | -8.16% |
| Dec 31, 2021 | 273.84M | -43.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 594.72M |
| Fusen Pharmaceutical Company | 584.05M |
| Zhongzhi Pharmaceutical Holdings | 569.98M |
| Wai Yuen Tong Medicine Holdings | 401.18M |
| Regent Pacific Group | 215.94M |
| Shenzhen Neptunus Interlong Bio-technique Company | 208.07M |
| Extrawell Pharmaceutical Holdings | 171.10M |
| Tianda Pharmaceuticals | 161.25M |